These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11777213)

  • 21. Postresection Outcomes of Combined Hepatocellular Carcinoma-Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
    Yoon YI; Hwang S; Lee YJ; Kim KH; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Lee JW; Hong SM; Yu ES; Lee SG
    J Gastrointest Surg; 2016 Feb; 20(2):411-20. PubMed ID: 26628072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnostic value of computed tomography for the detection of invasion of the caudate bile duct branch in carcinoma of the hepatic hilum].
    Nagino M; Nimura Y; Hayakawa N; Kamiya J; Kondoh S; Shionoya S
    Nihon Geka Gakkai Zasshi; 1988 Jun; 89(6):889-97. PubMed ID: 2847003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors.
    Jarnagin WR; Weber S; Tickoo SK; Koea JB; Obiekwe S; Fong Y; DeMatteo RP; Blumgart LH; Klimstra D
    Cancer; 2002 Apr; 94(7):2040-6. PubMed ID: 11932907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A 42-month disease free survival case of combined hepatocellular-cholangiocarcinoma with lymph node metastases treated with multimodal therapy].
    Hayashi H; Beppu T; Ishiko T; Mizumoto T; Masuda T; Okabe K; Baba Y; Okabe H; Takamori H; Kanemitsu K; Hiroto M; Baba H
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1941-3. PubMed ID: 17212153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases.
    Yano Y; Yamamoto J; Kosuge T; Sakamoto Y; Yamasaki S; Shimada K; Ojima H; Sakamoto M; Takayama T; Makuuchi M
    Jpn J Clin Oncol; 2003 Jun; 33(6):283-7. PubMed ID: 12913082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A comparative study of intrahepatic cholangiocarcinoma and hepatocellular carcinoma with reference to clinical features and prognosis].
    Hu JY; Zhou HB; Liu WD; Zhang J; Hu HP; Liu J
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jul; 27(7):511-515. PubMed ID: 31357776
    [No Abstract]   [Full Text] [Related]  

  • 27. MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma.
    Sammon J; Fischer S; Menezes R; Hosseini-Nik H; Lewis S; Taouli B; Jhaveri K
    Cancer Imaging; 2018 Feb; 18(1):8. PubMed ID: 29486800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraductal ultrasonography for hepatocellular carcinoma with tumor thrombi in the bile duct: comparison with polypoid cholangiocarcinoma.
    Tamada K; Isoda N; Wada S; Tomiyama T; Ohashi A; Satoh Y; Ido K; Sugano K
    J Gastroenterol Hepatol; 2001 Jul; 16(7):801-5. PubMed ID: 11446890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synchronous double cancers of primary hepatocellular carcinoma and intrahepatic cholangiocarcinoma: a case report and review of the literature.
    Wu C; Bai DS; Jiang GQ; Jin SJ
    World J Surg Oncol; 2014 Nov; 12():337. PubMed ID: 25385169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatocellular carcinoma with obstructive jaundice: diagnosis, treatment and prognosis.
    Qin LX; Tang ZY
    World J Gastroenterol; 2003 Mar; 9(3):385-91. PubMed ID: 12632482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differentiation of mass-forming intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma: based on the multivariate analysis of contrast-enhanced computed tomography findings.
    Zhao YJ; Chen WX; Wu DS; Zhang WY; Zheng LR
    Abdom Radiol (NY); 2016 May; 41(5):978-89. PubMed ID: 27193795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A case of sarcomatoid combined hepatocellular-cholangiocarcinoma].
    Jeong BJ; Hyun DH; Lee KW; Ryu ST; Lee JW; Lee JI; Jeong S; Lee DH; Kim PS; Kim HG; Kim YS; Kim JM
    Korean J Gastroenterol; 2004 Jan; 43(1):56-60. PubMed ID: 14745254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinicopathologic features and diagnosis of mixed type hepatocellular carcinoma].
    Lu J; Lin Z; Yuan S
    Zhonghua Zhong Liu Za Zhi; 1995 May; 17(3):208-11. PubMed ID: 7656828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathologic features and prognosis of combined hepatocellular cholangiocarcinoma.
    Koh KC; Lee H; Choi MS; Lee JH; Paik SW; Yoo BC; Rhee JC; Cho JW; Park CK; Kim HJ
    Am J Surg; 2005 Jan; 189(1):120-5. PubMed ID: 15701504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B virus-related combined hepatocellular-cholangiocarcinoma: clinicopathological and prognostic analysis of 390 cases.
    Chu KJ; Lu CD; Dong H; Fu XH; Zhang HW; Yao XP
    Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):192-9. PubMed ID: 24370644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term prognosis of combined hepatocellular and cholangiocarcinoma after curative resection comparison with hepatocellular carcinoma and cholangiocarcinoma.
    Lee JH; Chung GE; Yu SJ; Hwang SY; Kim JS; Kim HY; Yoon JH; Lee HS; Yi NJ; Suh KS; Lee KU; Jang JJ; Kim YJ
    J Clin Gastroenterol; 2011 Jan; 45(1):69-75. PubMed ID: 20142755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A successful resection and long-term survival of a patient with intrahepatic recurrences of combined hepatocellular-cholangiocarcinoma: report of a case.
    Eguchi H; Nagano H; Sakon M; Miyamoto A; Kondo M; Arai I; Morimoto O; Dono K; Umeshita K; Nakamori S; Wakasa K; Monden M
    Surg Today; 2002; 32(8):742-6. PubMed ID: 12181730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sonographic features of an intraductal polypoid mass: differentiation between hepatocellular carcinoma and intraductal cholangiocarcinoma.
    Kim NR; Kim SH; Lee JM; Lee KH; Kim YJ; An SK; Jung AY; Han JK; Choi BI
    J Ultrasound Med; 2004 Oct; 23(10):1283-91. PubMed ID: 15448317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary Hepatic Carcinosarcoma Composed of Hepatocellular Carcinoma, Cholangiocarcinoma, Osteosarcoma and Rhabdomyosarcoma With Poor Prognosis.
    Liu LI; Ahn E; Studeman K; Campbell K; Lai J
    Anticancer Res; 2020 Apr; 40(4):2225-2229. PubMed ID: 32234918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined hepatocellular and cholangiocarcinoma: CT findings with emphasis on multiphasic helical CT.
    Phongkitkarun S; Srisuwan T; Sornmayura P; Jatchavala J
    J Med Assoc Thai; 2007 Jan; 90(1):113-20. PubMed ID: 17621741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.